Trials / Conditions / Streptococcus Pneumoniae Vaccines

Streptococcus Pneumoniae Vaccines

9 registered clinical trials studyying Streptococcus Pneumoniae Vaccines.

Status	Trial	Sponsor	Phase
Completed	Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When A NCT01746108	GlaxoSmithKline	Phase 3
Completed	Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synfl NCT01641133	GlaxoSmithKline	Phase 3
Completed	Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam NCT01153841	GlaxoSmithKline	Phase 3
Completed	Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine NCT00624819	GlaxoSmithKline	Phase 3
Completed	Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants NCT00609492	GlaxoSmithKline	Phase 3
Completed	Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age NCT00489554	GlaxoSmithKline	Phase 3
Completed	Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccin NCT00463437	GlaxoSmithKline	Phase 3
Completed	Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine NCT00307541	GlaxoSmithKline	Phase 3
Completed	Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population. NCT00307008	GlaxoSmithKline	Phase 2